期刊文献+

抗核抗体谱阳性的视神经脊髓炎患者的临床和磁共振特征分析 被引量:9

Clinical and magnetic resonance imaging features of neuromyelitis optics with positive anti-nuclear antibody serum
原文传递
导出
摘要 目的探讨血清抗核抗体谱(ANAs)阳性的视神经脊髓炎(NMO)患者的临床和脑、脊髓磁共振成像特征。方法将2006--2011年首都医科大学宣武医院收治的34例视神经脊髓炎,分为抗核抗体谱阳性组(14例)和抗核抗体谱阴性组(20例),回顾性分析两组NMO患者的临床资料[包括首次发作的残疾状态扩展评分(EDSS)、首次缓解期持续时间、第一年复发阳性率等],总结脑、脊髓磁共振成像特征。结果(1)NMO抗核抗体谱阳性组和阴性组首次发作EDSS评分分别为(2.8±1.1)分、(2.3±0.8)分,首次缓解期持续时间分别为(9±9)个月、(31±39)个月,第一年复发阳性比例分别为10/14、6/20,两组之间差异有统计学意义(P〈0.05)。(2)NMO抗核抗体谱阳性组的磁共振脑损害阳性率为5/14,高于抗核抗体谱阴性组(5/20),但二者之间差异无统计学意义;抗核抗体谱阳性组颈段脊髓单独受累多于胸段脊髓(分别为6/14、1/14),抗核抗体谱阴性组胸段脊髓单独受累多于颈髓(分别为6/20、4/20)。结论抗核抗体谱阳性的NMO患者临床首次发作神经功能损伤严重,缓解期短,第一年内疾病易复发,易出现脑损害及颈段脊髓损害。 Objective To analyze the clinical features and brain, spinal cord magnetic resonance imaging (MRI) features of neuromyelitis optica (NMO)patients with positive anti-nuclear antibody serum (ANAs). Methods The clinical data of expanded disability status scale (EDSS) score, duration of the first relieving phase and first year recurrence-positive rate and MRI features of 34 NMO patients at our hospital during the period of 2006 - 2011 were retrospectively reviewed and divided into two groups according to the outcome of antibodies test : ANAs positive group ( n = 14) and ANAs negative group ( n = 20). Results ( 1 ) In the ANAs-positive group, the EDSS score of first NMO attack was (2. 8 ± 1.1 ), first remission continued to (9 ±9)months and the first year recurrence-positive rate was 71.0% ; in the ANAs-negative group, the EDSS score of first NMO attack was 2. 3 ±0. 8, first remission continued to (31 ± 39) months and the first year recurrence-positive rate was 30. 0%. The differences in the first attack EDSS score, duration of first remission and first recurrence rate between two groups were statistically significant (P 〈 0. 05). (2) Brain damage-positive rate in the ANAs-positive group on prompt MRI was 35.71% (5/14) and it was higher than that in ANAs-negative group (5/20). But no significant difference existed between two groups. The spinal cord lesions were predominantly located in cervical and thoracic spinal cords simultaneously in both groups (about 50% respectively). And, in the ANAs-positive group, the cervical lesions involved were much more common than the thoracic counterparts (6/14 vs 1/14). However, in the ANAs-negative group, thoracic segments were usually involved (6/20 vs 4/20). Conclusion With severe neurological deficits in the first clinical attack and a short remission, ANAs-positive NMO patients are more prone to relapse in the first year, brain damage and cervical cord injury.
出处 《中华医学杂志》 CAS CSCD 北大核心 2012年第43期3042-3045,共4页 National Medical Journal of China
关键词 视神经脊髓炎 抗体 抗核 临床表现 磁共振成像 Neuromyelitis optica Anti-nuclear antibody Clinical features Magnetic resonance imaging
  • 相关文献

参考文献11

二级参考文献42

  • 1Wingerchuk DM,Hogancamp WF,O'Brien PC,et al.The clinical course of neuromyelitis optica (Devic's syndrome).Neurology,1999,53:1107-1114.
  • 2Lennon VA,Wingerchuk DM,Kryzer TJ,et al.A serum autoantibody marker of neuromyelitis optica:distinction from multiple sclerosis.Lancet,2004,364:2106-2112.
  • 3Pittock SJ,Lennon VA,de Seze JD,et al.Neuromyelitis optica and non organ-specific autoimmunity.Arch Neurol,2008,65:78-83.
  • 4Roussel V,Yi F,Jauberteau MO,et al.Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis:a study of 89 patients.J Autoimmun,2000,14:259-265.
  • 5Tourbah A,Clapin A,Gout O,et al.Systemic autoimmune features and multiple sclerosis:a 5-year follow-up study.Arch Neurology,1998,55:517-521.
  • 6Wingerchuk DM,Lennon VA,Lucchinetti CF,et al.The spectrum of neuromyelitis optica.Lancet Neurol,2007,6:805-815.
  • 7Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica.Neurology,2006,66:1485-1489.
  • 8Papais-Alvarenga RM,Miranda-Santos CM,Puccioni-Sohler M,et al.Optic neuromyelitis syndrome in Brazilian patients.J Neurol Neurosurg Psychiatry,2002,73:429-435.
  • 9Cabrera-Gómez JA,Quevedo-Sotolongo L,González-Quevedo A,et al.Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.Mult Scler,2007,13:186-192.
  • 10Takahashi T,Fujihara K,Nakashima I,et al.Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO:a study on antibody titre.Brain,2007,130(Pt 5):1235-1243.

共引文献34

同被引文献47

  • 1李妙嫦,李蕊,杨渝,卢婷婷,邱伟,王玉鸽.伴其他自身免疫相关抗体的视神经脊髓炎谱系疾病临床特点分析[J].中国现代神经疾病杂志,2020(9):794-799. 被引量:3
  • 2Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica[J]. Lancet Neurol, 2007, 6(9):805-815.
  • 3Zhang B, Zhong Y, Wang Y, et al. Neuromyelitis optica spectrum disorders without and with autoimmune diseases [ J]. BMC Neurol, 2014, 14: 162.
  • 4Pittock S J, Lennon VA, de Seze J, et al. Neuromyelitis optica and non-organ-specific autoimmunity [ J ]. Arch Neurol, 2008, 65( 1 ) :78-83.
  • 5Freitas E, Guimaraes J. Neuromyelifis opfica spectrum disorders associated with other autoimmune diseases [ J]. Rheumatol Int, 2015, 35 ( 2 ) : 243-253.
  • 6Wingerchuk DM, Weinshenker BG. The emerging rela- tionship between neuromyelifis opfica and systemic rheu- matologic autoimmune disease[ J]. Mult Scler, 2012, 18(1) :5-10.
  • 7Wingerchuk DM, Banwell B, Bennett JL, et al. Interna- tional consensus diagnostic criteria for neuromyelitis opti- ca spectrum disorders [J ]. Neurology, 2015, 85 (2) : 177-189.
  • 8Kim W, Kim SH, Lee SH, et al. Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder[J]. Mult Scler, 2011, 17(9) :1107-1112.
  • 9Iyer A, Elsone L, Appleton R, et al. A review of thecurrent literature and a guide to the early diagnosis of au- toimmune disorders associated with neuromyelitis optica[J]. Autoimmunity, 2014, 47(3) :154-161.
  • 10Bienia B, Balabanov R. Immunotherapy of neuromyeli- tis optica [ J ]. Autoimmune Dis, 2013, 2013 : 741490.

引证文献9

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部